Questions and answers on the outcome of assessment to extend the use of Valdoxan (agomelatine)
Withdrawn application: Scenesse, 24/04/2024
First vaccine to protect adults from Chikungunya
Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Scientific guideline
Summary of opinion: Kinpeygo, 30/05/2024 Positive
Summary of opinion: Livmarli, 30/05/2024 Positive
Summary of opinion: Eliquis, 30/05/2024 Positive
Summary of opinion: Skyrizi, 30/05/2024 Positive
New gene therapy treatment for haemophilia B
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa